The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Helius Medical Technologies Inc (NASDAQ: HSDT) was $0.67 for the day, down -8.21% from the previous closing price of $0.73. In other words, the price has decreased by -$8.21 from its previous closing price. On the day, 0.1 million shares were traded. HSDT stock price reached its highest trading level at $0.729 during the session, while it also had its lowest trading level at $0.62.
Ratios:
Our analysis of HSDT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.09 and its Current Ratio is at 3.61. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Noble Capital Markets on March 24, 2021, initiated with a Outperform rating and assigned the stock a target price of $20.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HSDT now has a Market Capitalization of 2497874 and an Enterprise Value of -4369714. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.00 while its Price-to-Book (P/B) ratio in mrq is 0.64. Its current Enterprise Value per Revenue stands at -7.356 whereas that against EBITDA is 0.369.
Stock Price History:
The Beta on a monthly basis for HSDT is 1.48, which has changed by -0.91307735 over the last 52 weeks, in comparison to a change of 0.23806548 over the same period for the S&P500. Over the past 52 weeks, HSDT has reached a high of $9.50, while it has fallen to a 52-week low of $0.37. The 50-Day Moving Average of the stock is 14.36%, while the 200-Day Moving Average is calculated to be -53.85%.
Shares Statistics:
HSDT traded an average of 2.39M shares per day over the past three months and 379490 shares per day over the past ten days. A total of 3.73M shares are outstanding, with a floating share count of 3.68M. Insiders hold about 1.42% of the company’s shares, while institutions hold 2.17% stake in the company. Shares short for HSDT as of 1730332800 were 225384 with a Short Ratio of 0.07, compared to 1727654400 on 59173. Therefore, it implies a Short% of Shares Outstanding of 225384 and a Short% of Float of 6.38.
Earnings Estimates
Helius Medical Technologies Inc (HSDT) is currently under the scrutiny of 1 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.92, with high estimates of -$0.92 and low estimates of -$0.92.
Analysts are recommending an EPS of between -$5.64 and -$5.64 for the fiscal current year, implying an average EPS of -$5.64. EPS for the following year is -$2.5, with 1.0 analysts recommending between -$2.5 and -$2.5.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 1 analysts. It ranges from a high estimate of $100k to a low estimate of $100k. As of the current estimate, Helius Medical Technologies Inc’s year-ago sales were $134kFor the next quarter, 1 analysts are estimating revenue of $100k. There is a high estimate of $100k for the next quarter, whereas the lowest estimate is $100k.
A total of 1 analysts have provided revenue estimates for HSDT’s current fiscal year. The highest revenue estimate was $468k, while the lowest revenue estimate was $468k, resulting in an average revenue estimate of $468k. In the same quarter a year ago, actual revenue was $644kBased on 1 analysts’ estimates, the company’s revenue will be $510k in the next fiscal year. The high estimate is $510k and the low estimate is $510k.
